| Heading: |
Cystic Fibrosis: Drugs |
| Question ID: |
1787626 |
| UIN: |
40475 |
| House: |
Commons |
| Date tabled: |
2025-03-24 |
| Asking Member ID: |
4131 |
| Asking Member display name: |
Jim Shannon
|
| Asking Member handle: |
jimshannonmp
|
| Asking Member Twitter reference: |
@jimshannonmp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he has had discussions with the National Institute for Health and Social Care on the accessibility of new medicines to treat cystic fibrosis. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-31 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department has regular discussions with the National Institute for Health and Care Excellence (NICE) about access to various new medicines.The NICE develops its recommendations for the National Health Service in England based on the clinical and cost ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |